P ulmonary hypertension is a chronic cardiopulmonary disorder characterized by progressive increasing pulmonary vascular resistance, leading to right ventricular heart failure. 1 Prevalence of pulmonary hypertension is estimated to be 10 to 15 cases per million with a mortality rate of 15% per year. 2 Over the past 2 decades, targeted pharmacological therapies have been effective in reducing disease progression and improving the survival rate among patients with pulmonary hypertension. 3,4 However, most patients remain symptomatic with significant exercise intolerance and reduced quality of life despite being on optimal medical therapy. 5,6 Thus, there is an unmet need for adjunctive therapeutic strategies to improve exercise tolerance and quality of life among these patients.
in pulmonary hypertension and these conditions, it can be hypothesized that similar benefits of exercise training may be derived in patients with pulmonary hypertension. Several small studies have evaluated exercise training as an adjunctive therapeutic strategy in patients with chronic pulmonary hypertension. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Although most of these studies were small and not designed to address clinical end points, such as mortality or hospitalizations, related to pulmonary hypertension, they have demonstrated a variable degree of improvement in exercise tolerance and quality of life in response to training.
Therefore, because of the uncertainty about the benefit of structured exercise training programs in patients with pulmonary hypertension, we performed this systematic review and meta-analysis to assess the efficacy and safety of structured exercise training regimens in patients with pulmonary hypertension.
Methods
This study is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 31 
Data Sources and Searches
A comprehensive computerized literature search of Medline and EMBASE databases was conducted using MeSH terms and keywords, including pulmonary hypertension, pulmonary arterial hypertension, pulmonary arterial hypertension, exercise, exercise training, pulmonary rehabilitation, cardiac rehabilitation, and cardiopulmonary rehabilitation, for articles published between January 1, 1960, and April 15, 2015. We only included human studies involving adult participants in our literature search. In addition, the institutional records were manually searched for available theses using the expertise of a medical librarian.
Study Selection and Outcomes of Interest
We evaluated all prospective intervention studies, including parallel group trials (both randomized as well as nonrandomized trials) with an intervention and a control group, and pre-post intervention studies that enrolled adult patients (age ≥18 years) with pulmonary arterial hypertension of any cause (Figure 1 ). The primary outcome of our study was change in exercise capacity measured as 6-minute walk distance (6MWD) from baseline to follow-up. Secondary outcomes included change in cardiorespiratory fitness (measured as change in peak oxygen uptake in mL/kg per minute), resting pulmonary arterial systolic pressure, peak exercise heart rate, and quality of life parameters, as indicated by the SF-36 questionnaire subscale scores (physical functioning, role physical, general health perception, vitality, social functioning, and mental health). Studies failing to report at least 1 of the above predefined study outcomes were excluded from our analysis. We also evaluated the safety profile of exercise training by determining the pooled incidence of adverse events in the included studies as detailed below.
Data Extraction
Full text articles were retrieved for all title abstracts that met the inclusion criteria. Data extraction was then independently performed by 2 authors (A.P. and M.K.) using a standardized questionnaire. All discrepancies about study inclusion or outcomes were resolved by the senior author (J.B.). In cases of multiple publications arising from a single trial, only the updated trial publication with the maximum number of patients was included. The following information was recorded for each study: author, year of publication, nature of study, baseline demographic and clinical characteristics, baseline invasive measures of pulmonary artery pressure, pre and post exercise intervention measures of outcome variables (6MWD, peak oxygen uptake, and SF-36 score), dropout rates, and adverse events. Both fatal and nonfatal adverse events among the exercise-training participants were recorded.
Data Synthesis and Statistical Analysis
Pooled analysis was conducted using Metan and Metareg functions available for Stata version 12.1 statistical software (Stata Corporation, College Station, TX) 32 and Comprehensive Meta-analysis Software (Biostat, Englewood, NJ). In each trial, the effect size of exercise training was calculated as the difference between preintervention and postintervention measure of the continuous outcome variables (6MWD and peak oxygen uptake) in the aerobic exercise-trained participants. Each mean difference was weighted according to the inverse variance method 33 and pooled across each trial using a random effects model. 34 We also analyzed the trials with parallel intervention and control arms separately and calculated the effect size of the exercise training intervention as the difference in the change in outcome variables after intervention between exercise-trained participants and control group participants. We assessed for heterogeneity using the I 2 statistic (I 2 ≥50% was assumed to be a result of significant heterogeneity). To assess the effect of age on treatment outcomes, random effects metaregression models were constructed for the primary outcome (6MWD). We also evaluated the overall safety profile of exercise training in the included studies by determining the pooled dropout rate and frequency of adverse events during exercise training. Because the majority of our included studies were not randomized trials, we calculated the pooled incidence of adverse events (fatal and nonfatal) among the exercisetraining participants of the included studies. Risk of bias analysis for the randomized intervention trials was performed using Cochrane collaboration's assessment tool in RevMan version 5.2 software. 35 Quality assessment of pre-post interventional studies was performed using the National Institutes of Health quality assessment tool. Publication bias was assessed using the funnel plots and quantified by Begg's Mazumdar test. All P values were 2-tailed with statistical significance specified at 0.05 and confidence intervals (CI) reported at the 95% level.
Results

Study Characteristics
We included 16 studies with 469 participants (69% women) in the final meta-analysis. Pooled analysis included exercise training participants enrolled in 6 parallel group trials with an intervention and a control arm (4 randomized and 2 nonrandomized trials) and 10 pre-post studies. One study with duplicate population was included in descriptive review but not in the pooled analysis. 30 The median follow-up duration was 15 weeks (range, 3-40 weeks). Baseline demographic and clinical characteristics of the study participants are summarized in Table 1 . One study (Ihle et al 25 ) did not provide information on underlying cause of pulmonary hypertension among study participants. Among others studies, the majority of training participants had class I pulmonary hypertension or class IV pulmonary hypertension ( Table I in the Data Supplement) and a small proportion had class II pulmonary hypertension related to left heart disease or class III pulmonary hypertension secondary to chronic lung disease. 36 All studies included well-compensated patients with pulmonary hypertension stabilized on cardiac medications with no recent hospitalizations. Common exclusion criteria used in the studies were the presence of New York Heart Association class I or class IV symptoms or coexisting conditions that impaired their participation in training (Tables II and III in the Data  Supplement) . Supervised exercise-training protocols were used in all studies with a combination of aerobic (treadmill or cycle ergometer) and resistance training. Six studies trained patients with pulmonary hypertension at outpatient rehabilitation centers; 9 studies performed in-hospital exercise training for the first few weeks followed by home-based exercise training; and 1 study included only home-based training protocol. Training participants in the majority of included studies underwent low workload aerobic exercise training (10-60 W) with some form of resistance and respiratory training. Exercise intensity was titrated at 60% to 80% of peak exercise capacity in most studies. The study participants had exercise capacity and cardiorespiratory fitness assessment at baseline and follow-up (Tables  2 and 3 ).
Quality Assessment
The Cochrane risk of bias assessment tool was used to perform quality assessment of controlled intervention trials. During quality assessment, random sequence generation and blinded assessment of outcomes were performed in 4 and 3 of the 6 included trials, respectively. Incomplete outcome data or selective reporting of results were not observed in any of the selected studies. Quality assessment of pre-post interventional studies has been detailed in Table IV in the Data Supplement. All included studies had a clearly stated study question, prespecified inclusion criteria, participants representative of the pulmonary hypertension patient population in the real world, clearly defined intervention and outcome variables, and a low proportion of loss to follow-up. Potential risks of biases were lack of information on blinding of the assessment of the outcomes and lack of multiple measurements of outcomes of interest before and after exercise intervention. We did not observe a significant risk of publication bias for the primary outcome in the included studies (Egger's regression intercept=−1.32; P value=0.36; Figure 
Effect of Exercise Training on 6MWD
All included studies reported 6MWD at baseline and after exercise training. Mean 6MWD at baseline among training participants in the included studies was 416.9 m (SD, 37.0). We observed a significant heterogeneity on pooled analysis of studies reporting 6MWD (I 2 =87%) at baseline and follow-up. Pooling across all studies using random effects analysis showed that exercise training was associated with a significant improvement in 6MWD from baseline to follow-up. (weighted mean difference [WMD], 53.3 m; 95% CI, 39.5-67.2; Figure 2A ). Meta-regression did not show a significant association of baseline age with the change in 6MWD after exercise training (P value=0.13; Figure II in the Data Supplement). We also performed sensitivity analyses including only data from trials with parallel intervention and Figure 2B ).
Effect of Exercise Training on Peak Oxygen Uptake
Nine studies reported peak relative oxygen uptake (mL/kg per minute) at baseline and after exercise training, whereas 6 studies reported data on change in peak absolute oxygen uptake (mL/min). The mean peak relative oxygen uptake at baseline in the included studies was 12.5 mL/kg per minute (SD, 2.4). We observed a significant heterogeneity on pooled analysis of studies reporting peak relative (mL/ kg per minute; I 2 =56.5%) and absolute oxygen uptake (mL/ min; I 2 =63.8%) at baseline and follow-up. Pooling across all studies that reported peak oxygen uptake at baseline and after exercise training showed that exercise training was associated with a significant improvement in peak relative oxygen uptake (WMD, 1.8 mL/kg per minute; 95% CI, 1.4-2.3; Figure 3A ) and peak absolute oxygen uptake (WMD, 135.8 mL/min; 95% CI, 80.1-191.5; Figure 3B ) from baseline to follow-up.
Effect of Exercise Training on Resting Pulmonary Arterial Systolic Pressure
Eight studies estimated resting pulmonary arterial systolic pressure among study participants using Doppler echocardiography (n=7 studies) or right heart cath (n=1 study) before and after exercise training. Pooling across these studies showed that exercise training was associated with a significant improvement in resting pulmonary artery systolic pressure from baseline to follow-up (WMD, −3.7 mm Hg; 95% CI, −5.4 to −1.9; Figure 4A ). Furthermore, we did not observe any significant heterogeneity among the studies included in the pooled analysis (I 2 =0.0%)
Effect of Exercise Training on Peak Exercise Heart Rate
Nine studies reported the peak exercise heart rate among study participants before and after exercise training. Pooling across these studies showed that exercise training was associated with a significant improvement in peak exercise heart rate from baseline to follow-up (WMD, 10 beats per min; 95% CI, 6-15; Figure 4B ).
Effect of Exercise Training on Quality of Life
Impact of exercise training on quality of life was assessed in detail in 4 pre-post intervention trials. Pooled analysis across these 4 studies showed a significant improvement in quality of life as measured by the SF-36 questionnaire subscale scores ( Table 4 ).
Safety of Exercise Training
Exercise training was well tolerated among the participants of most included studies. On pooled analysis, overall dropout rate from exercise training was <1%. Episodes of dizziness, presyncope, syncope, palpitations, hypotension, or oxygen desaturation were observed in 4.7% of training participants, two-third of which were related to exercise training. Episodes of respiratory and nonrespiratory infections that lead to an interruption in exercise training occurred in 6.6% participants. Furthermore, no major adverse events, such as progression of symptoms, progression of PH, right heart failure, or death, were reported among the participants during the training period ( Table 5 ). Four pre-post training studies reported long-term follow-up data (>2 years) among exercise-training participants (n=134). On median follow-up of 29.5 months (range, 21-36 months), the proportion of participants alive was 91% (12 deaths), and the proportion of participants with transplant-free survival was 89%. Grünig et al 2011 18 Grünig et al 2012 19 Grünig et al 2012 20 Nagel et al 2012 27 Becker-Grünig et al 2013 21 Kabitz et al 2014 24
• 3 wk supervised training followed by 12 wk training at home 
Discussion
The principal finding of this systematic review and meta-analysis of patients with established chronic pulmonary hypertension is that exercise training is associated with a significant improvement in exercise capacity and cardiorespiratory fitness from baseline to follow-up (Δ 6MWD, 53.3 m; Δ peak VO 2 , 1.8 mL/kg per minute). There was also a significant reduction in resting pulmonary arterial systolic pressure and an improvement in peak exercise heart rate after exercise training (Δ pulmonary arterial systolic pressure, 3.7 mm Hg; Δ peak exercise heart rate, 10 beats per minute). Furthermore, exercise training was well tolerated among these patients and was associated with significant improvements in quality of life. Taken together, these findings suggest that exercise training could be used as a safe and effective adjunctive treatment strategy among stable and well-compensated patients with chronic pulmonary hypertension.
Our study has important clinical implications. Exercise training and cardiac rehabilitation are strongly recommended for patients with chronic cardiopulmonary conditions, such as heart failure and COPD. 12, 13 Similarly, the recent treatment guidelines for pulmonary hypertension have upgraded the recommendations for exercise training among these patients to a class IA status. 37 However, clinicians have traditionally been skeptical about the use of exercise training and cardiopulmonary rehabilitation for management of chronic pulmonary hypertension because of concerns of exertional syncope and progressive right ventricular dysfunction with strenuous physical activity. [38] [39] [40] Contrary to these notions, our study findings provide comprehensive evidence in favor of efficacy and safety of exercise training in patients with pulmonary hypertension and highlight its potential role as an adjunct to medical therapy designed to alleviate symptoms in patients with pulmonary hypertension.
We observed significant improvements in exercise tolerance, measured as 6MWD, with exercise training. Previous studies have established an association between 6MWD and long-term clinical outcomes in patients with pulmonary hypertension. 41 In a recent study, improvement in 6MWD of >41.8 m was found to correlate with lower odds of a clinical event at 12 weeks. 42 As a result, improvement in 6MWD has been used as a surrogate end point in pulmonary hypertension clinical trials. 43 In this study, we observed up to 53 m improvement in 6MWD at 15 weeks with exercise training on pooled analysis, which is greater than that reported with pulmonary hypertension-specific pharmacotherapies. 44 Furthermore, we observed significant improvement in resting systolic pulmonary arterial pressure with exercise training, suggesting that exercise training has a favorable disease-modifying effect, similar to that observed with well-established pharmacotherapies. 44 Future studies are needed to determine whether these favorable effects of exercise training can translate into a reduction in long-term major adverse clinical outcomes. 14, [17] [18] [19] [20] [21] [22] 27, 29 and peak absolute oxygen uptake (mL/min) on pooled analysis of included studies (n=6, B). 14, [19] [20] [21] 27, 29 CI indicates confidence interval.
The mechanisms underlying improvement in exercise tolerance with exercise training among patients with pulmonary hypertension are not well understood. Studies in animal models of pulmonary hypertension have shown that exercise training is associated with improvement in endothelium-dependent relaxation in the pulmonary circulation, favorable remodeling of pulmonary vasculature, and reduced right ventricle enddiastolic pressure. 45, 46 Furthermore, recent human studies have shown that exercise training is associated with significant improvements in central pulmonary perfusion and peripheral skeletal muscle function, which could also contribute to the training-related improvement in exercise capacity. 16, 23 In this study, we observed a significant improvement in the pulmonary arterial systolic pressure with training, which could lead to significant reductions in pulmonary vascular resistance and a concomitant improvement in blood flow through the pulmonary vascular system. Improved pulmonary perfusion would be associated with improved oxygenation and cardiac output, thus leading to improvement in exercise tolerance and cardiorespiratory fitness. We also observed a significant increase in peak exercise heart rate with exercise training that could contribute toward improvement in cardiorespiratory fitness among patients with pulmonary hypertension. This is consistent with the findings among patients with heart failure, where partial reversal of the chronotropic incompetence has been shown to contribute to improvements in exercise capacity with exercise training. 47 The findings from this study also support the safety profile of exercise training among well-compensated patients with pulmonary hypertension. We observed a high degree of tolerance to training with low dropout rates and exercise-associated adverse events comparable with that observed with exercise training in patients with heart failure. 48 Furthermore, the rate of major adverse events, such as right heart failure, mortality, and worsening pulmonary hypertension observed on pooled analysis, was much lower than that reported in pulmonary 14, 17, [19] [20] [21] [27] [28] [29] and peak exercise heart rate (n=9, B). 14, [17] [18] [19] [20] [21] [22] 27, 29 CI indicates confidence interval.
hypertension-specific pharmacotherapy trials. In a meta-analysis of randomized control trials performed in patients with pulmonary hypertension, Galie et al 44 reported an overall mortality rate of 1.5% in the actively treated group in 14 weeks of mean observation period. In contrast, no deaths were reported among the exercise-training participants across all the included studies in the 15 weeks of median training period. This could be related to the difference in severity of the condition between participants with pulmonary hypertension recruited for pharmacotherapy trials versus exercise training studies. The rate of nonexercise-related adverse events, such as infections, was also not different from what has been reported in pulmonary hypertension registries. 49 Taken together, our study findings suggest that exercise training regimens can be safely implemented for management of chronic pulmonary hypertension.
Several important aspects of exercise training protocols implemented in the included studies are noteworthy. All studies used supervised exercise training protocols, particularly for the first few weeks of training. Furthermore, the exercisetraining protocols used in most studies were at a lower workload when compared with current exercise recommendations for heart failure patients. 50 Moreover, the majority of exercisetraining participants belonged to class I or class IV pulmonary hypertension, therefore, the benefits of exercise training observed in this may not be applicable to patients with other classes of pulmonary hypertension. Finally, exercise training was implemented only in medically stable patients with no recent change in the medication regimen. These characteristics should be considered when recommending exercise training to patients with pulmonary hypertension.
There are several limitations in this study. First, we only have a limited number of clinical trials that have assessed the safety and efficacy of exercise training among patients with pulmonary hypertension. Two of the 6 parallel group trials included in the pooled analysis were nonrandomized, and the sample size of included studies is small. This highlights the significance of pooled analysis that has been conducted in this study. Second, most of the included studies have not evaluated clinical end points, such as mortality and hospitalization events; therefore, we were unable to assess the impact of exercise training on these clinical end points. Third, it is difficult to evaluate the sustainability of effects of exercisetraining intervention on exercise capacity among patients with pulmonary hypertension in this study. Fourth, most of the included studies were single-center based and had a relatively short duration of follow-up. Future multicenter randomized control trials with longer duration follow-up are needed to 26 4
Exercise intolerance with cyanosis in 2 patients Fox et al 2011 17 11 None Chan et al 2013 22 10 None Ley et al 2013 23 10 None Weinstein et al 2013 30 11 None Ehlken et al 2015 29 46 None Becker-Grünig et al 2013 21 20 None Grünig et al 2012 20 21 None Grünig et al 2011 18 58 Dizziness with training in 2 patients Grünig et al 2012 19 183 Presyncope in 1 patient after training Self-limiting tachycardia in 2 patients during exercise Mainguy et al 2010 16 5 None Nagel et al 2012 27 35 Syncope during exercise in 1 patient Herpes zoster in 1 patient De Man et al 2009 15 19 Minor dizziness in 2 patients Kabitz et al 2014 24 7 None Inagaki et al 2014 28 8
One patient with hypotension during training Ihle et al 2014 25 17 None better characterize the long-term benefits of exercise training in these patients. Finally, as with all meta-analyses, selection bias cannot be completely ruled out because articles were only retrieved from published trials.
In conclusion, exercise training is associated with significant improvement in exercise capacity, cardiorespiratory fitness, and quality of life among patients with pulmonary hypertension. Future studies with longer follow-up duration are needed to determine whether exercise training can be used to improve long-term clinical outcomes among these patients in the real world.
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